Barr Sues To Block Generic Seasonale

Law360, New York (December 14, 2007, 12:00 AM EST) -- Barr Pharmaceuticals Inc. subsidiary Duramed Pharmaceuticals Inc. is asserting a patent reissued in September against Watson Pharmaceuticals Inc. and Sandoz Inc., looking to keep Sandoz out of the multimillion-dollar market for the oral contraceptive Seasonale, and arguing that Watson's Quasense contraceptive should be taken off the market.

Thursday, Duramed filed separate complaints against Watson and Sandoz in the U.S. District Court for the District of New Jersey, asking the court to issue a permanent injunction blocking the defendants from making oral contraceptive products that infringe the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.